Aribio Lab Co., Ltd.: Clinical Trials

6 trials sponsored by Aribio Lab Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Recruiting 1
Phase 24Completed 3, Not yet recruiting 1

Follow Aribio Lab Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
Shingrix, CVI-VZV-001 - Herpes Zoster
Phase 2Not yet recruitingAribio Lab Co., Ltd.1352026-04-012026-03-19
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
CVI-VZV-001, Shingrix - Vaccine-Preventable Diseases, Herpes Zoster
Phase 1RecruitingAribio Lab Co., Ltd.322023-03-152024-11-19
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
CVI-HBV-002 - Vaccine-Preventable Diseases, Hepatitis B
Phase 1CompletedAribio Lab Co., Ltd.302021-09-172024-03-25
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
CVI-HBV-002, Normal Saline(placebo) - Hepatitis B, Chronic
Phase 2CompletedAribio Lab Co., Ltd.1342020-02-192024-02-13
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
CVI-HBV-002 - Hepatitis B, Chronic
Phase 1 / Phase 2CompletedAribio Lab Co., Ltd.532014-10-282023-11-18
A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine
CVI-HBV-001, Conventional Hepatitis B vaccine (20 μg) - Healthy
Phase 1 / Phase 2CompletedAribio Lab Co., Ltd.752012-12-072023-11-18

Conditions studied

Hepatitis B, Chronic (2)  ·  Herpes Zoster (2)  ·  Vaccine-Preventable Diseases (2)  ·  Chickenpox (1)  ·  Hepatitis B (1)

Countries

South Korea (5)

Top investigators

Jeonghyeon Choi (1)  ·  Joon Hyeok Lee (1)  ·  Kyu-Sung Rim, M.D., Ph.D. (1)  ·  Seong Gyu Hwang, M.D., Ph.D. (1)  ·  Youngsang Kim (1)